Guia Ladrera

891 total citations · 1 hit paper
4 papers, 423 citations indexed

About

Guia Ladrera is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Guia Ladrera has authored 4 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 1 paper in Cancer Research. Recurrent topics in Guia Ladrera's work include Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Guia Ladrera is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Guia Ladrera collaborates with scholars based in Thailand, China and Taiwan. Guia Ladrera's co-authors include Yi‐Long Wu, Chong‐Jen Yu, Tony Mok, Matt Truman, Sumitra Thongprasert, Vichien Srimuninnimit, Virote Sriuranpong, Jennifer Sandoval-Tan, Barbara Klughammer and David S. Shames and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Guia Ladrera

4 papers receiving 419 citations

Hit Papers

Detection and Dynamic Changes of EGFR Mutations from Circ... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
    2015 367 citations Tony Mok, Yi‐Long Wu et al. Clinical Cancer Research profile →

Peers

Guia Ladrera
Fatima Fuerte Philippines
Takako Okuyama Japan
S. Patel United Kingdom
Giampaolo Filice Italy
Anna Buder Austria
Roxanne Nemati United States
David Boucher United States
B Bartlett United States
Barbora Belšánová Czechia
Andrea E. Doak United States
Fatima Fuerte Philippines
Guia Ladrera
Citations per year, relative to Guia Ladrera Guia Ladrera (= 1×) peers Fatima Fuerte

Countries citing papers authored by Guia Ladrera

Since Specialization
Citations

This map shows the geographic impact of Guia Ladrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guia Ladrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guia Ladrera more than expected).

Fields of papers citing papers by Guia Ladrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guia Ladrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guia Ladrera. The network helps show where Guia Ladrera may publish in the future.

Co-authorship network of co-authors of Guia Ladrera

This figure shows the co-authorship network connecting the top 25 collaborators of Guia Ladrera. A scholar is included among the top collaborators of Guia Ladrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guia Ladrera. Guia Ladrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
2.
Mok, Tony, Yi‐Long Wu, Jin Soo Lee, et al.. (2015). Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. Clinical Cancer Research. 21(14). 3196–3203. 367 indexed citations breakdown →
3.
4.
Mok, Tony, Yi‐Long Wu, Sumitra Thongprasert, et al.. (2012). A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II.. Journal of Clinical Oncology. 30(15_suppl). 7519–7519. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatima Fuerte Breakdown of academic impact, for papers by Takako Okuyama Breakdown of academic impact, for papers by S. Patel Breakdown of academic impact, for papers by Giampaolo Filice Breakdown of academic impact, for papers by Anna Buder Breakdown of academic impact, for papers by Roxanne Nemati Breakdown of academic impact, for papers by David Boucher Breakdown of academic impact, for papers by B Bartlett Breakdown of academic impact, for papers by Barbora Belšánová Breakdown of academic impact, for papers by Andrea E. Doak
Rankless by CCL
2026